Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by Vanqua Bio Vanqua Bio to Present at Inaugural GBA1 2024 Meeting June 20, 2024 From Vanqua Bio Via GlobeNewswire Vanqua Bio Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating VQ-101, its Small Molecule GCase Activator for GBA-Parkinson’s Disease and Related Disorders April 09, 2024 From Vanqua Bio Via GlobeNewswire Vanqua Bio to Present at the Stifel 2024 CNS Days Conference March 13, 2024 From Vanqua Bio Via GlobeNewswire Vanqua Bio to Present Pre-Clinical Data on VQ-101, a Novel GCase Activator For The Treatment of GBA-Parkinson’s Disease February 27, 2024 From Vanqua Bio Via GlobeNewswire Vanqua Bio Advances Clinical Candidate for Parkinson’s Disease, Expands Leadership Team to Support Further Development December 12, 2023 From Vanqua Bio Via GlobeNewswire Vanqua Bio to Participate in the Leerink Partners Biopharma Private Company Connect October 18, 2023 From Vanqua Bio Via GlobeNewswire Vanqua Bio to Present at the Stifel 2023 CNS Day Conference March 22, 2023 From Vanqua Bio Via GlobeNewswire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.